Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757724
Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal WomenMacao Polytechnic UniversityCompletedNot Applicable
NCT07757724Completed
Not Applicable
Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal WomenMacao Polytechnic Univers...
NCT07756944
Effects of Bubble Cushion Exercises on Postural Control in Children With Down SyndromeRiphah International UniversityCompletedNot Applicable
NCT07756944Completed
Not Applicable
Effects of Bubble Cushion Exercises on Postural Control in Children With Down Sy...Riphah International Univ...
NCT07757802
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy AdultsNational Institute of Allergy and Infectious Diseases (NIAID)Not Yet RecruitingPhase 1
NCT07757802Not Yet Recruiting
Phase 1
Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Ad...National Institute of All...
NCT07758166
The First-Night Effect and Sex Differences in Strength and Muscular Endurance PerformanceUniversity of AlcalaCompletedNot Applicable
NCT07758166Completed
Not Applicable
The First-Night Effect and Sex Differences in Strength and Muscular Endurance Pe...University of Alcala
NCT07757022
AI-Driven Digital Twin and Drug Simulation for Esophageal CancerHenan Cancer HospitalNot Yet Recruiting
NCT07757022Not Yet Recruiting
—
AI-Driven Digital Twin and Drug Simulation for Esophageal CancerHenan Cancer Hospital
NCT07757971
2D:4D Ratio in Relation to Anxiety and Stress Among Anesthesiology ResidentsAin Shams UniversityNot Yet Recruiting
NCT07757971Not Yet Recruiting
—
2D:4D Ratio in Relation to Anxiety and Stress Among Anesthesiology ResidentsAin Shams University
NCT07758673
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic LymphomaCity of Hope Medical CenterNot Yet RecruitingPhase 1
NCT07758673Not Yet Recruiting
Phase 1
Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed o...City of Hope Medical Cent...
NCT07757568
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fumarate (Tecfidera) or Diroximel Fumarate (Vumerity)University of Colorado, DenverActive Not Recruiting
NCT07757568Active Not Recruiting
—
Prospective Evaluation of De-Escalation From antiCD-20 Therapies to Dimethyl Fum...University of Colorado, D...
NCT07757594
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen LeNot Yet RecruitingNot Applicable
NCT07757594Not Yet Recruiting
Not Applicable
FARES Versus Traction-Countertraction for Acute Anterior Shoulder DislocationNgoc Quyen Le
NCT07757113
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolizationphenox Inc.Not Yet RecruitingNot Applicable
NCT07757113Not Yet Recruiting
Not Applicable
Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergo...phenox Inc.
NCT07758231
Impact of GLP-1 Receptor Agonist Therapy on Alcohol PharmacokineticsUniversity of Wisconsin, MadisonNot Yet RecruitingPhase 1
NCT07758231Not Yet Recruiting
Phase 1
Impact of GLP-1 Receptor Agonist Therapy on Alcohol PharmacokineticsUniversity of Wisconsin,...
NCT07758647
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial) SystemsInstitut de Recherches Cliniques de MontrealNot Yet RecruitingNot Applicable
NCT07758647Not Yet Recruiting
Not Applicable
NO-Meal Announcement in Automated Insulin Delivery (Open-source and Commercial)...Institut de Recherches Cl...
NCT07757906
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADTPS) in Endoscopic Submucosal DissectionQilu Hospital of Shandong UniversityNot Yet RecruitingNot Applicable
NCT07757906Not Yet Recruiting
Not Applicable
Clinical Application of an AI-based Dissection Trajectory Prediction System (ADT...Qilu Hospital of Shandong...
NCT07758881
A Prospective Study Evaluating the Safety and Performance of the Eight Medical Hyperthermia System IV 1.0 for HIVEC in NMIBC.Eight Medical International BVNot Yet RecruitingNot Applicable
NCT07758881Not Yet Recruiting
Not Applicable
A Prospective Study Evaluating the Safety and Performance of the Eight Medical H...Eight Medical Internation...
NCT07758075
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Injection in Patients With Plaque PsoriasisGuangdong Hengrui Pharmaceutical Co., LtdNot Yet RecruitingPhase 2
NCT07758075Not Yet Recruiting
Phase 2
A Phase II Clinical Study to Evaluate the Efficacy and Safety of SHR-1139 Inject...Guangdong Hengrui Pharmac...
NCT07758660
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Aging (NIA)Enrolling By InvitationPhase 2
NCT07758660Enrolling By Invitation
Phase 2
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Agi...
NCT07758907
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Screening SystemCenExelEnrolling By InvitationNot Applicable
NCT07758907Enrolling By Invitation
Not Applicable
Interference and Stability Evaluation of the Intelligent Fingerprinting Drug Scr...CenExel
NCT07758712
Effectiveness of a Horse Riding Simulator in Adolescents With Idiopathic ScoliosisBezmialem Vakif UniversityRecruitingNot Applicable
NCT07758712Recruiting
Not Applicable
Effectiveness of a Horse Riding Simulator in Adolescents With Idiopathic Scolios...Bezmialem Vakif Universit...
NCT07756996
Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingPhase 1
NCT07756996Recruiting
Phase 1
Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Am...CSPC ZhongQi Pharmaceutic...
Result Breakdown
Not yet recruiting11 (55%)
Completed4 (20%)
Enrolling by invitation2 (10%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Phase 14 (20%)
Not Specified4 (20%)
Phase 22 (10%)